Adnan Deronic

472 total citations
14 papers, 289 citations indexed

About

Adnan Deronic is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Adnan Deronic has authored 14 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Adnan Deronic's work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Adnan Deronic is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Adnan Deronic collaborates with scholars based in Sweden, Denmark and France. Adnan Deronic's co-authors include Tomas Leanderson, Fredrik Ivars, Peter Ellmark, Per Norlén, Anette Sundstedt, Anneli Nilsson, Niina Veitonmäki, Dorte Nielsen, Jeffrey Yachnin and Gustav Ullenhag and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Adnan Deronic

13 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adnan Deronic Sweden 10 195 126 98 29 24 14 289
Xuexiao Jin China 8 168 0.9× 132 1.0× 143 1.5× 19 0.7× 18 0.8× 15 338
Georgina Flórez‐Grau Netherlands 12 246 1.3× 127 1.0× 65 0.7× 15 0.5× 14 0.6× 22 335
Dang-Nghiem Vo France 9 160 0.8× 102 0.8× 116 1.2× 12 0.4× 14 0.6× 13 313
Gage Brummer United States 7 135 0.7× 150 1.2× 97 1.0× 51 1.8× 25 1.0× 8 335
Hongyan Huang China 6 120 0.6× 130 1.0× 122 1.2× 11 0.4× 25 1.0× 8 271
Vanessa Klapp United States 6 103 0.5× 111 0.9× 76 0.8× 15 0.5× 21 0.9× 13 219
Maria McSharry United States 5 157 0.8× 129 1.0× 141 1.4× 11 0.4× 49 2.0× 8 330
Emine Gulsen Gunes United States 8 132 0.7× 103 0.8× 85 0.9× 16 0.6× 9 0.4× 15 243
Kathryn M LaPorte United States 4 200 1.0× 141 1.1× 67 0.7× 26 0.9× 19 0.8× 7 303
Yohei Saito Japan 5 156 0.8× 131 1.0× 179 1.8× 10 0.3× 28 1.2× 7 383

Countries citing papers authored by Adnan Deronic

Since Specialization
Citations

This map shows the geographic impact of Adnan Deronic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adnan Deronic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adnan Deronic more than expected).

Fields of papers citing papers by Adnan Deronic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adnan Deronic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adnan Deronic. The network helps show where Adnan Deronic may publish in the future.

Co-authorship network of co-authors of Adnan Deronic

This figure shows the co-authorship network connecting the top 25 collaborators of Adnan Deronic. A scholar is included among the top collaborators of Adnan Deronic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adnan Deronic. Adnan Deronic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Millrud, Camilla Rydberg, Adnan Deronic, Elin Jaensson Gyllenbäck, et al.. (2022). Blockade of IL-1α and IL-1β signaling by the anti-IL1RAP antibody nadunolimab (CAN04) mediates synergistic anti-tumor efficacy with chemotherapy. Cancer Immunology Immunotherapy. 72(3). 667–678. 13 indexed citations
2.
3.
Deronic, Adnan, et al.. (2021). Abstract 1593: Mitazalimab, a potent CD40 agonist with potential for combination with chemotherapy. Cancer Research. 81(13_Supplement). 1593–1593. 1 indexed citations
4.
Deronic, Adnan, et al.. (2021). Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy. Expert Opinion on Biological Therapy. 21(12). 1635–1646. 22 indexed citations
5.
6.
Ellmark, Peter, Karin Hägerbrand, Laura von Schantz, et al.. (2020). 858 A bispecific antibody targeting CD40 and EpCAM induces superior anti-tumor effects compared to the combination of the monospecific antibodies. SHILAP Revista de lepidopterología. A511.1–A511. 4 indexed citations
7.
Irenaeus, Sandra, Dorte Nielsen, Peter Ellmark, et al.. (2019). First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies. International Journal of Cancer. 145(5). 1189–1199. 76 indexed citations
8.
Dahlman, Anna, Michelle H. Nelson, Anneli Nilsson, et al.. (2019). Abstract 2380: Preclinical safety and efficacy of a tumor-directed T cell activating 4-1BB x 5T4 ADAPTIR™ bispecific antibody. Cancer Research. 79(13_Supplement). 2380–2380. 2 indexed citations
9.
Deronic, Adnan, et al.. (2018). The immunomodulatory quinoline-3-carboxamide paquinimod reverses established fibrosis in a novel mouse model for liver fibrosis. PLoS ONE. 13(9). e0203228–e0203228. 26 indexed citations
10.
11.
12.
Olsson, Anders, Anette Sundstedt, Pascale Plas, et al.. (2015). Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment. Journal for ImmunoTherapy of Cancer. 3(1). 53–53. 56 indexed citations
13.
Sundstedt, Anette, et al.. (2013). Amelioration of Experimental Autoimmune Encephalomyelitis by the Quinoline-3-Carboxamide Paquinimod. American Journal Of Pathology. 182(5). 1671–1680. 26 indexed citations
14.
Deronic, Adnan, et al.. (2013). The quinoline-3-carboxamide paquinimod (ABR-215757) reduces leukocyte recruitment during sterile inflammation: Leukocyte- and context-specific effects. International Immunopharmacology. 18(2). 290–297. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuexiao Jin Breakdown of academic impact, for papers by Georgina Flórez‐Grau Breakdown of academic impact, for papers by Dang-Nghiem Vo Breakdown of academic impact, for papers by Gage Brummer Breakdown of academic impact, for papers by Hongyan Huang Breakdown of academic impact, for papers by Vanessa Klapp Breakdown of academic impact, for papers by Maria McSharry Breakdown of academic impact, for papers by Emine Gulsen Gunes Breakdown of academic impact, for papers by Kathryn M LaPorte Breakdown of academic impact, for papers by Yohei Saito
Rankless by CCL
2026